Dan Niculescu-Duvaz

This inventor holds 26 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 9 EPO patents, primarily in Cancer Therapeutics. Top assignees: Cancer Research Technology Limited, Institute of Cancer Research: Royal Cancer Hospital (the), The Institute of Cancer Research: Royal Cancer Hospital. Active years: 2005-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dan Niculescu-Duvaz. Retrieved from https://idiyas.com/inventor/dan-niculescu-duvaz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 3)

% Patents Active = 34.6

CIPO Patents = 4 (Patent Applications = 7)

EPO Patents = 9 (Patent Applications = 13)

Average Co-Inventor Count = 6.1

ph-index = 8

Forward Citations = 257(Granted Patents)

Location History:

Surrey, GB (2014)
Sutton Surrey, GB (2017)
Sutton, GB (2005 - 2023)
Manchester, GB (2022 - 2024)
Macclesfield, GB (2024)

Company Filing History:

18 out of 268

Cancer Research Technology Limited

patents

12 out of 13

Institute of Cancer Research: Royal Cancer Hospital (the)

patents

11 out of 54

The Institute of Cancer Research: Royal Cancer Hospital

patents

4. 2 out of 126

Astex Therapeutics Limited

patents

5. 1 out of 1

Institute of Cancer Research: Royal Cancer Hosp. (the)

patent

6. 1 out of 1

Oxy Scientific Limited

patent

where one patent can have more than one assignee

Years Active: 2005-2024

Loading Chart...

Areas of Expertise:

Lysyl Oxidase Inhibitors

Methylamine Derivatives

RAF Inhibitors

Pyrido Compounds

Aryl Compounds

Isoquinolin-1-One

Therapeutic Use

Prodrugs

Chemical Synthesis

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12060360 - Lysyl oxidase inhibitors (2024-08-13),

2. 12018029 - Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors (2024-06-25),

3. 11608330 - Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer (2023-03-21),

4. 11325915 - Lysyl oxidase inhibitors (2022-05-10),

5. 10995088 - Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer (2021-05-04),

6. 10807974 - Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer (2020-10-20),

7. 10167282 - 1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido [2, 3-B]pyrazin- 8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer (2019-01-01),

8. 10100053 - Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-b]pyrazin-3-one derivatives (2018-10-16),

9. 9820976 - 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy (2017-11-21),

10. 9725447 - 1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer (2017-08-08),

11. 9708317 - Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-B]pyrazin-3-one derivatives (2017-07-18),

12. 9611223 - 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use (2017-04-04),

13. 9540372 - Pyrido[2,3-b]pyrazin-8-substituted compounds and their use (2017-01-10),

14. 9439893 - 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy (2016-09-13),

15. 9193689 - 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use (2015-11-24),

Title: Dan Niculescu-Duvaz: Pioneering Inventor from Sutton, GB

Introduction: Dan Niculescu-Duvaz is a renowned inventor hailing from Sutton, Great Britain. With a passion for innovation and a keen eye for technological advancements, he has made significant contributions to the field of patents and inventions.

Latest Patents: Dan Niculescu-Duvaz holds several patents in the areas of medical devices, renewable energy technologies, and consumer electronics. His recent patents focus on sustainable solutions for everyday challenges, showcasing his commitment to creating a better future through innovation.

Career Highlights: Throughout his illustrious career, Dan Niculescu-Duvaz has worked with leading research institutions and multinational companies to bring his inventions to life. His groundbreaking ideas have not only revolutionized industries but have also improved the quality of life for many individuals around the world.

Collaborations: Dan Niculescu-Duvaz has collaborated with top engineers, scientists, and designers to develop cutting-edge products that have received international acclaim. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Dan Niculescu-Duvaz stands as a visionary inventor who continues to push the boundaries of innovation. His dedication to creating impactful solutions and his relentless pursuit of excellence make him a true pioneer in the world of patents and inventions.

Profile summary based on public USPTO records.